GHRPs may have potential for screening ACTH-dependent Cushing's syndrome as plasma ACTH levels are greatly increased in response to GHRP administration in patients with Cushing's disease compared with normal subjects. Here, POMC is linked to Cushing syndrome due to macronodular adrenal hyperplasia.